Eiger BioPharmaceuticals, Inc. (EIGR) - Stock Prices, Stock Peers & Analysis

Home
EIGR

Company Name	Eiger BioPharmaceuticals, Inc.
Symbol	EIGR
Currency	USD
Price	1.725
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	2,552,120
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.1 - 43.35
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. David Apelian M.B.A., M.D., MBA, Ph.D.
Website	https://www.eigerbio.com

An error occurred while fetching data.

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus